-
1دورية أكاديمية
المؤلفون: Brugières, Laurence, Cozic, Nathalie, Houot, Roch, Rigaud, Charlotte, Sibon, David, Arfi-Rouche, Julia, Bories, Pierre, Cottereau, Anne S, Delmer, Alain, Ducassou, Stéphane, Garnier, Nathalie, Lamant, Laurence, Leruste, Amaury, Millot, Frédéric, Moalla, S., Morschhauser, Franck, Nolla, Marie, Pagnier, Anne, Reguerre, Yves, Renaud, Loïc, Schmitt, Anne, Simonin, Mathieu, Verschuur, Arnaud, Labouret, Nathalie Hoog, Mahier Ait-Oukhatar, Celine, Vassal, Gilles
المساهمون: AP-HP. Université Paris Saclay, Institut Gustave Roussy (IGR), Oncostat (U1018 (Équipe 2)), Institut Gustave Roussy (IGR)-Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Service de biostatistique et d'épidémiologie (SBE), Direction de la recherche clinique Gustave Roussy, Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou, Université de Rennes (UR), CHU Henri Mondor Créteil, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), AP-HP - Hôpital Cochin Broca Hôtel Dieu Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Université Paris Descartes - Paris 5 (UPD5), Hôpital universitaire Robert Debré Reims (CHU Reims), Université de Reims Champagne-Ardenne (URCA), Centre Hospitalier Universitaire de Bordeaux (CHU de Bordeaux), Institut d'hématologie et d'oncologie pédiatrique CHU - HCL (IHOPe), Hospices Civils de Lyon (HCL), Centre de Recherches en Cancérologie de Toulouse (CRCT), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Curie Paris, Université Paris Sciences et Lettres (PSL), CIC Poitiers – Centre d'investigation clinique de Poitiers (CIC 1402), Université de Poitiers = University of Poitiers (UP)-Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie )-Direction Générale de l'Organisation des Soins (DGOS)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie ), Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 (GRITA), Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre Hospitalier Universitaire CHU Grenoble (CHUGA), Centre Hospitalier Universitaire de La Réunion (CHU La Réunion), Hopital Saint-Louis AP-HP (AP-HP), Université Paris-Sud - Paris 11 (UP11), Institut Bergonié Bordeaux, UNICANCER, CHU Trousseau APHP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Hôpital de la Timone CHU - APHM (TIMONE), Institut national du cancer (INCa), This programme was founded by the INCa, the ARC Foundation for Cancer Research, and Unicancer’s personalised medicine research partners. This work was institutionally supported by Pfizer. No grant number is applicable.
المصدر: ISSN: 0959-8049 ; European Journal of Cancer ; https://hal.science/hal-04228222Test ; European Journal of Cancer, 2023, 191, pp.112984. ⟨10.1016/j.ejca.2023.112984⟩.
مصطلحات موضوعية: Anaplastic large-cell lymphoma ALK plus, Crizotinib, ALK inhibitors, MESH: Adolescent, MESH: Adult, MESH: Protein-Tyrosine Kinases / therapeutic use, MESH: Proto-Oncogene Proteins, MESH: Receptor Protein-Tyrosine Kinases / therapeutic use, MESH: Young Adult, MESH: Anaplastic Lymphoma Kinase, MESH: Child, MESH: Crizotinib / therapeutic use, MESH: Humans, MESH: Lung Neoplasms* / drug therapy, MESH: Lymphoma, Large-Cell, Anaplastic* / drug therapy, MESH: Neoplasm Recurrence, Local / drug therapy, MESH: Protein Kinase Inhibitors / adverse effects, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37549532; hal-04228222; https://hal.science/hal-04228222Test; https://hal.science/hal-04228222/documentTest; https://hal.science/hal-04228222/file/2023_Cozic_EurJCancer.pdfTest; PUBMED: 37549532
الإتاحة: https://doi.org/10.1016/j.ejca.2023.112984Test
https://hal.science/hal-04228222Test
https://hal.science/hal-04228222/documentTest
https://hal.science/hal-04228222/file/2023_Cozic_EurJCancer.pdfTest -
2دورية أكاديمية
المؤلفون: Bonnet, C., Poullot, E., Bachy, E., Cavalieri, D., Fataccioli, V., Bregnard, C., Drieux, F., Bruneau, J., Lemonnier, F., Dupuy, A., Bossard, C., Parrens, M., Bouabdallah, K., Ketterer, N., Berthod, G., Cairoli, A., Damaj, G., Tournilhac, O., Jais, J.P.
المصدر: Haematologica, vol. 108, no. 6, pp. 1590-1603
مصطلحات موضوعية: Humans, Receptor Protein-Tyrosine Kinases/genetics, Anaplastic Lymphoma Kinase/genetics, Brentuximab Vedotin/therapeutic use, Disease-Free Survival, Lymphoma, Large-Cell, Anaplastic/diagnosis, Anaplastic/drug therapy, Anaplastic/genetics, In Situ Hybridization, Fluorescence
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36453105; info:eu-repo/semantics/altIdentifier/eissn/1592-8721; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3ECE36010A352; https://serval.unil.ch/notice/serval:BIB_3ECE36010A35Test; urn:issn:0390-6078; https://serval.unil.ch/resource/serval:BIB_3ECE36010A35.P002/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3ECE36010A352Test
الإتاحة: https://doi.org/10.3324/haematol.2022.281442Test
https://serval.unil.ch/notice/serval:BIB_3ECE36010A35Test
https://serval.unil.ch/resource/serval:BIB_3ECE36010A35.P002/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_3ECE36010A352Test -
3دورية أكاديمية
المؤلفون: Jungels, Christiane, Pita, Jaime Miguel, Costante, Giuseppe
المصدر: Current opinion in oncology, 35 (1
مصطلحات موضوعية: Cancérologie, Humans, Thyroid Carcinoma, Anaplastic -- drug therapy -- genetics, Thyroid Neoplasms -- drug therapy -- genetics, anaplastic thyroid carcinoma, BRAF, immunotherapy, targeted therapy
وصف الملف: 1 full-text file(s): application/pdf
العلاقة: uri/info:doi/10.1097/CCO.0000000000000918; uri/info:pii/00001622-990000000-00063; uri/info:pmid/36398690; uri/info:scp/85143645163; https://dipot.ulb.ac.be/dspace/bitstream/2013/360715/3/Jungels_anaplastic_CCO_2022.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/360715Test
-
4دورية أكاديمية
المساهمون: V Subbiah, R J Kreitman, Z A Wainberg, J Y Cho, J H M Schellens, J C Soria, P Y Wen, C C Zielinski, M E Cabanillas, A Boran, P Ilankumaran, P Burgess, T Romero Salas, B Keam
مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols* / adverse effects, Humans, Imidazoles / therapeutic use, Mutation, Oximes / therapeutic use, Proto-Oncogene Proteins B-raf / genetics, Pyridones / therapeutic use, Pyrimidinones / therapeutic use, Thyroid Carcinoma, Anaplastic* / drug therapy, Anaplastic* / genetics, Thyroid Neoplasms* / drug therapy, Thyroid Neoplasms* / genetics, BRAF, anaplastic thyroid cancer, dabrafenib, targeted therapy, trametinib
العلاقة: ANNALS OF ONCOLOGY; J00171; OAK-2022-10487; https://ir.ymlib.yonsei.ac.kr/handle/22282913/194423Test; T9992023081; ANNALS OF ONCOLOGY, Vol.33(4) : 406-415, 2022-04
الإتاحة: https://doi.org/10.1016/j.annonc.2021.12.014Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194423Test -
5دورية أكاديمية
المؤلفون: Liang, H.C., Costanza, M., Prutsch, N., Zimmerman, M.W., Gurnhofer, E., Montes-Mojarro, I.A., Abraham, B.J., Prokoph, N., Stoiber, S., Tangermann, S., Lobello, C., Oppelt, J., Anagnostopoulos, I., Hielscher, T., Pervez, S., Klapper, W., Zammarchi, F., Silva, D.A., Garcia, K.C., Baker, D., Janz, M., Schleussner, N., Fend, F., Pospíšilová, Š., Janiková, A., Wallwitz, J., Stoiber, D., Simonitsch-Klupp, I., Cerroni, L., Pileri, S., de Leval, L., Sibon, D., Fataccioli, V., Gaulard, P., Assaf, C., Knörr, F., Damm-Welk, C., Woessmann, W., Turner, S.D., Look, A.T., Mathas, S., Kenner, L., Merkel, O.
المصدر: Nature communications, vol. 12, no. 1, pp. 5577
مصطلحات موضوعية: Animals, Basic-Leucine Zipper Transcription Factors/genetics, Basic-Leucine Zipper Transcription Factors/metabolism, Cell Line, Tumor, Cell Proliferation/drug effects, Cell Survival/drug effects, Gene Expression Regulation, Neoplastic, Humans, Immunoconjugates/pharmacology, Interleukin-15/pharmacology, Interleukin-2/pharmacology, Interleukin-2 Receptor alpha Subunit/genetics, Interleukin-2 Receptor alpha Subunit/immunology, Interleukin-2 Receptor alpha Subunit/metabolism, Ki-1 Antigen/genetics, Ki-1 Antigen/metabolism, Lymphoma, Large-Cell, Anaplastic/drug therapy, Anaplastic/genetics, Anaplastic/metabolism, Anaplastic/pathology, Mice, Receptors, Interleukin-2/genetics, Interleukin-2/immunology, Interleukin-2/metabolism, Regulatory Sequences
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34552066; info:eu-repo/semantics/altIdentifier/eissn/2041-1723; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_E40D4F85C9A72; https://serval.unil.ch/notice/serval:BIB_E40D4F85C9A7Test; urn:issn:2041-1723; https://serval.unil.ch/resource/serval:BIB_E40D4F85C9A7.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E40D4F85C9A72Test
الإتاحة: https://doi.org/10.1038/s41467-021-25379-9Test
https://serval.unil.ch/notice/serval:BIB_E40D4F85C9A7Test
https://serval.unil.ch/resource/serval:BIB_E40D4F85C9A7.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_E40D4F85C9A72Test -
6دورية أكاديمية
المصدر: ECHELON-2 Study Group 2019 , ' Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2) : a global, double-blind, randomised, phase 3 trial ' , Lancet (London, England) , vol. 393 , no. 10168 , pp. 229-240 . https://doi.org/10.1016/S0140-6736Test(18)32984-2
مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cyclophosphamide/administration & dosage, Disease-Free Survival, Double-Blind Method, Doxorubicin/administration & dosage, Female, Humans, Immunoconjugates/administration & dosage, Immunologic Factors/administration & dosage, Intention to Treat Analysis, Lymphoma, Large-Cell, Anaplastic/drug therapy, Male, Middle Aged, Prednisone/administration & dosage, Vincristine/administration & dosage, ResearchInstitutes_Networks_Beacons/lydia_becker_institute_of_immunology_and_inflammation, name=Lydia Becker Institute, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1016/S0140-6736Test(18)32984-2
https://research.manchester.ac.uk/en/publications/4ce422c9-a1da-4c56-83d6-b88bf66adb9eTest
https://pure.manchester.ac.uk/ws/files/133770819/THELANCETPUBLICHEALTH_S_19_00758_2_.pdfTest -
7دورية أكاديمية
المؤلفون: Horwitz, Steven, O'Connor, Owen A, Pro, Barbara, Illidge, Tim, Fanale, Michelle, Advani, Ranjana, Bartlett, Nancy L, Christensen, Jacob Haaber, Morschhauser, Franck, Domingo-Domenech, Eva, Rossi, Giuseppe, Kim, Won Seog, Feldman, Tatyana, Lennard, Anne, Belada, David, Illés, Árpád, Tobinai, Kensei, Tsukasaki, Kunihiro, Yeh, Su-Peng, Shustov, Andrei, Hüttmann, Andreas, Savage, Kerry J, Yuen, Sam, Iyer, Swaminathan, Zinzani, Pier Luigi, Hua, Zhaowei, Little, Meredith, Rao, Shangbang, Woolery, Joseph, Manley, Thomas, Trümper, Lorenz
المصدر: Horwitz , S , O'Connor , O A , Pro , B , Illidge , T , Fanale , M , Advani , R , Bartlett , N L , Christensen , J H , Morschhauser , F , Domingo-Domenech , E , Rossi , G , Kim , W S , Feldman , T , Lennard , A , Belada , D , Illés , Á , Tobinai , K , Tsukasaki , K , Yeh , S-P , Shustov , A , Hüttmann , A , Savage , K J , Yuen , S , Iyer , ....
مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Cyclophosphamide/administration & dosage, Disease-Free Survival, Double-Blind Method, Doxorubicin/administration & dosage, Female, Humans, Immunoconjugates/administration & dosage, Immunologic Factors/administration & dosage, Intention to Treat Analysis, Lymphoma, Large-Cell, Anaplastic/drug therapy, Male, Middle Aged, Prednisone/administration & dosage, Vincristine/administration & dosage
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/01911b31-02ec-4e43-85dc-e2e7c9245589Test
الإتاحة: https://doi.org/10.1016/S0140-6736Test(18)32984-2
https://portal.findresearcher.sdu.dk/da/publications/01911b31-02ec-4e43-85dc-e2e7c9245589Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436818/pdf/nihms-1515984.pdfTest -
8
المؤلفون: Liang, Huan-Chang, Costanza, Mariantonia, Prutsch, Nicole, Zimmerman, Mark W., Gurnhofer, Elisabeth, Montes-Mojarro, Ivonne A., Abraham, Brian J., Prokoph, Nina, Stoiber, Stefan, Tangermann, Simone, Lobello, Cosimo, Oppelt, Jan, Anagnostopoulos, Ioannis, Hielscher, Thomas, Pervez, Shahid, Klapper, Wolfram, Zammarchi, Francesca, Silva, Daniel-Adriano, Garcia, K. Christopher, Baker, David, Janz, Martin, Schleussner, Nikolai, Fend, Falko, Pospíšilová, Šárka, Janiková, Andrea, Wallwitz, Jacqueline, Stoiber, Dagmar, Simonitsch-Klupp, Ingrid, Cerroni, Lorenzo, Pileri, Stefano, de Leval, Laurence, Sibon, David, Fataccioli, Virginie, Gaulard, Philippe, Assaf, Chalid, Knörr, Fabian, Damm-Welk, Christine, Woessmann, Wilhelm, Turner, Suzanne D., Look, A. Thomas, Mathas, Stephan, Kenner, Lukas, Merkel, Olaf
المساهمون: Liang, Huan-Chang [0000-0003-2612-3714], Costanza, Mariantonia [0000-0002-8959-1083], Zimmerman, Mark W. [0000-0003-2489-3889], Montes-Mojarro, Ivonne A. [0000-0003-0636-7623], Abraham, Brian J. [0000-0001-8085-3027], Prokoph, Nina [0000-0002-6429-9895], Stoiber, Stefan [0000-0003-3293-867X], Oppelt, Jan [0000-0002-3076-4840], Klapper, Wolfram [0000-0001-7208-4117], Silva, Daniel-Adriano [0000-0002-3195-9009], Garcia, K. Christopher [0000-0001-9273-0278], Baker, David [0000-0001-7896-6217], Janz, Martin [0000-0002-1127-0044], Fend, Falko [0000-0002-5496-293X], de Leval, Laurence [0000-0003-3994-516X], Turner, Suzanne D. [0000-0002-8439-4507], Look, A. Thomas [0000-0001-7851-8617], Mathas, Stephan [0000-0001-9626-1413], Kenner, Lukas [0000-0003-2184-1338], Merkel, Olaf [0000-0001-5089-344X], Apollo - University of Cambridge Repository, Zimmerman, Mark W [0000-0003-2489-3889], Montes-Mojarro, Ivonne A [0000-0003-0636-7623], Abraham, Brian J [0000-0001-8085-3027], Garcia, K Christopher [0000-0001-9273-0278], Turner, Suzanne D [0000-0002-8439-4507], Look, A Thomas [0000-0001-7851-8617]
المصدر: Nature communications, vol. 12, no. 1, pp. 5577
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-12 (2021)مصطلحات موضوعية: CRISPR-Cas9 genome editing, Cancer Research, Immunoconjugates, Cell Survival, Science, Ki-1 Antigen, Regulatory Sequences, Nucleic Acid, 631/67/1990/291/1621/1916, 38/91, 96/95, Mice, Cell Line, Tumor, hemic and lymphatic diseases, Animals, Humans, Cell Proliferation, Interleukin-15, High-throughput screening, Interleukin-2 Receptor alpha Subunit, article, Receptors, Interleukin-2, Basic-Leucine Zipper Transcription Factors/genetics, Basic-Leucine Zipper Transcription Factors/metabolism, Cell Proliferation/drug effects, Cell Survival/drug effects, Gene Expression Regulation, Neoplastic, Immunoconjugates/pharmacology, Interleukin-15/pharmacology, Interleukin-2/pharmacology, Interleukin-2 Receptor alpha Subunit/genetics, Interleukin-2 Receptor alpha Subunit/immunology, Interleukin-2 Receptor alpha Subunit/metabolism, Ki-1 Antigen/genetics, Ki-1 Antigen/metabolism, Lymphoma, Large-Cell, Anaplastic/drug therapy, Lymphoma, Large-Cell, Anaplastic/genetics, Lymphoma, Large-Cell, Anaplastic/metabolism, Lymphoma, Large-Cell, Anaplastic/pathology, Receptors, Interleukin-2/genetics, Receptors, Interleukin-2/immunology, Receptors, Interleukin-2/metabolism, Repressor Proteins/genetics, Repressor Proteins/metabolism, Signal Transduction/drug effects, Xenograft Model Antitumor Assays, 45/15, 96/21, Repressor Proteins, 631/337/4041/3196, Mechanisms of disease, Basic-Leucine Zipper Transcription Factors, Interleukin-2, Lymphoma, Large-Cell, Anaplastic, T-cell lymphoma, 631/1647/2163, 631/80/304, 82/51, Signal Transduction
وصف الملف: application/pdf; application/zip; text/xml; application/vnd.openxmlformats-officedocument.wordprocessingml.document
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a2422edb39fce227889a8f8c1af0c166Test
https://www.repository.cam.ac.uk/handle/1810/328381Test -
9
المؤلفون: Stamatiou, A., Herrera-Gómez, R.G., Szturz, P., Bisig, B., Romano, E., Sykiotis, G., Gorostidi, F., La Rosa, S., Kopp, P., Cristina, V.
المصدر: Revue medicale suisse, vol. 17, no. 739, pp. 962-966
مصطلحات موضوعية: Humans, Mutation, Proto-Oncogene Proteins B-raf/genetics, Thyroid Carcinoma, Anaplastic/diagnosis, Thyroid Carcinoma, Anaplastic/drug therapy, Thyroid Carcinoma, Anaplastic/genetics, Thyroid Neoplasms/diagnosis, Thyroid Neoplasms/drug therapy, Thyroid Neoplasms/genetics
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1900::79186af505aa2162e726b6938eaa5d70Test
https://serval.unil.ch/resource/serval:BIB_E0FB351F6891.P001/REF.pdfTest -
10دورية أكاديمية
المؤلفون: Abate, F., Todaro, M., van der Krogt, J.A., Boi, M., Landra, I., Machiorlatti, R., Tabbò, F., Messana, K., Abele, C., Barreca, A., Novero, D., Gaudiano, M., Aliberti, S., Di Giacomo, F., Tousseyn, T., Lasorsa, E., Crescenzo, R., Bessone, L., Ficarra, E., Acquaviva, A., Rinaldi, A., Ponzoni, M., Longo, D.L., Aime, S., Cheng, M., Ruggeri, B., Piccaluga, P.P., Pileri, S., Tiacci, E., Falini, B., Pera-Gresely, B., Cerchietti, L., Iqbal, J., Chan, W.C., Shultz, L.D., Kwee, I., Piva, R., Wlodarska, I., Rabadan, R., Bertoni, F., Inghirami, G.
المساهمون: European T-cell Lymphoma Study Group, Abele, C., Bessone, L., Barreca, A., Boi, M., Cavallo, F., Chiesa, N., Crescenzo, R., Fienga, A., Gaudiano, M., di Giacomo, F., Inghirami, G., Landra, I., Lasorsa, E., Marchiorlatti, R., Martinoglio, B., Medico, E., Ferrero, GB., Messana, K., Mereu, E., Pellegrino, E., Piva, R., Scafò, I., Spaccarotella, E., Tabbò, F., Todaro, M., Ubezzi, I., Urigu, S., Novero, D., Chiapella, A., Vitolo, U., Abate, F., Ficarra, E., Acquaviva, A., Agnelli, L., Neri, A., Chilosi£££Anna Caliò Marco£££ AC., Zamó, A., Facchetti, F., Lonardi, S., De Chiara, A., Fulciniti, F., Ferreri, A., Ponzoni, M., Agostinelli, C., Piccaluga, PP., Pileri, S., Falini, B., Tiacci, E., Van Loo, P., Tousseyn, T., De Wolf-Peeters, C., Geissinger, E., Muller-Hermelink, HK., Rosenwald, A., Piris, MA., Rodriguez, ME., Bertoni, F., Rinaldi, A., Kwee, I., Chiattone, C., Paes, RA.
المصدر: Leukemia, vol. 29, no. 6, pp. 1390-1401
مصطلحات موضوعية: Animals, Blotting, Western, Drug Resistance, Neoplasm, Flow Cytometry, Gene Expression Profiling, High-Throughput Nucleotide Sequencing, Humans, Immunoprecipitation, In Situ Hybridization, Fluorescence, Lymphoma, Large-Cell, Anaplastic/drug therapy, Anaplastic/genetics, Mice, Inbred NOD, NF-kappa B/genetics, NF-kappa B/metabolism, Proteasome Inhibitors/pharmacology, Proto-Oncogene Proteins c-myc/genetics, Proto-Oncogene Proteins c-myc/metabolism, RNA, Messenger/genetics, Real-Time Polymerase Chain Reaction, Receptor Protein-Tyrosine Kinases/genetics, Receptor Protein-Tyrosine Kinases/metabolism, Repressor Proteins/genetics, Repressor Proteins/metabolism
وصف الملف: application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/25533804; info:eu-repo/semantics/altIdentifier/eissn/1476-5551; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_0D92E89F5C271; https://serval.unil.ch/notice/serval:BIB_0D92E89F5C27Test; urn:issn:0887-6924; https://serval.unil.ch/resource/serval:BIB_0D92E89F5C27.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_0D92E89F5C271Test
الإتاحة: https://doi.org/10.1038/leu.2014.347Test
https://serval.unil.ch/notice/serval:BIB_0D92E89F5C27Test
https://serval.unil.ch/resource/serval:BIB_0D92E89F5C27.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_0D92E89F5C271Test